Thursday - January 29, 2026

Category Archives: Marketing & Sales

Donanemab by Eli Lilly and Company expected to drive market size of Alzheimer’s Disease

Explore the comprehensive Donanemab market report by a leading healthcare research firm, offering detailed insights, sales forecasts, and market analysis up to 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth … Continue reading →

Spinal Cord Injury Market: Growth Momentum Across 7MM to 2034 – DelveInsight | Kringle Pharma, Neuroplast, Abbvie, Mitsubishi Tanabe Pharma, Lineage Cell Therapeutics, NervGen Pharma

The Key Spinal Cord Injury Companies in the market include – Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others.   DelveInsight’s “Spinal … Continue reading →

Artificial Intelligence in Drug Commercialization: Market Projected to Grow at 24.12% CAGR Through 2032 | DelveInsight

Artificial Intelligence (AI) in Drug Commercialization DelveInsight Business Research, a leading pharmaceutical market research and business consulting firm, has released its latest market intelligence report on AI in Drug Commercialization. The report profiles leading companies, including EVERSANA, Lyfegen, Syneos Health, … Continue reading →

AGC Biologics “TTHX-1114” Market size expansion of Several Folds by 2034

Explore DelveInsight’s comprehensive report on TTHX-1114 (AGC Biologics), featuring market landscape, sales forecast, and market size analysis through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on TTHX-1114 (AGC … Continue reading →

Nonalcoholic Steatohepatitis Market to Evolve Rapidly Over the Next Decade, DelveInsight Observes | Madrigal Pharmaceuticals, Novo Nordisk, 89bio

Nonalcoholic Steatohepatitis Diagnostics Market Insights, Epidemiology, and Market Forecast-2034 The Key Nonalcoholic Steatohepatitis Companies in the market include – Madrigal Pharmaceuticals, Novo Nordisk A/S, 89bio, Inc., Akero Therapeutics, Inc., Galectin Therapeutics, Sagimet Biosciences, Inventiva Pharma, Zydus Therapeutics, Eli Lilly and … Continue reading →

Hemophilia B Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Novo Nordisk, Sanofi, Pfizer, Belief BioMed, Centessa Pharmaceuticals

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hemophilia B pipeline constitutes 15+ key companies continuously working towards developing 20+ Hemophilia B treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Pulmonary Arterial Hypertension Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Ribomic, Gmax Biopharm, Novartis, Cereno Scientific AB, Insmed

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Pulmonary Arterial Hypertension pipeline constitutes 55+ key companies continuously working towards developing 55+ Pulmonary Arterial Hypertension treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Wiskott-Aldrich Syndrome Market to Evolve Rapidly Over the Next Decade, DelveInsight Observes | GlaxoSmithKline, Orchard Therapeutics, Genethon

Wiskott-Aldrich Syndrome Market Insights, Epidemiology, and Market Forecast-2032 The Key Wiskott-Aldrich Syndrome Companies in the market include – GlaxoSmithKline, Orchard Therapeutics, Genethon, Grifols Therapeutics LLC, Soma Jyonouchi, and others. The Wiskott-Aldrich Syndrome market is expected to surge due to the … Continue reading →